Last update 21 Dec 2024

LX102(Innostellar)

Overview

Basic Info

Drug Type
AAV based gene therapy
Synonyms
LX 102(Innostellar Biotherapeutics), LX-102(Innostellar Biotherapeutics), LX102(Innostellar Biotherapeutics)
+ [1]
Target
Mechanism
VEGF modulators(Vascular endothelial growth factor modulators)
Inactive Indication-
Inactive Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Wet age-related macular degenerationPhase 2
CN
19 Jan 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
6
LX102-C01 gene therapy 3 × 1010 vg
xrsbfbquwa(xcighwuoyg) = Intravitreal injection of LX102-C01 was safe and generally well tolerated during 2 years of follow up. No LX102-C01-related serious adverse events were noted; anterior uveitis was reported in 5 subjects, and were all generally mild and resolved with topical corticosteroid. No evidence of vasculitis, retinitis, choroiditis, vascular occlusions or endophthalmitis was reported. pzrczrrnsr (owhwyveumu )
Positive
19 Sep 2024
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free